Back to search

University of Southampton

Inhibiting the protein-protein interaction of B-cell lymphoma 6 using genetically selected cyclic peptide inhibitors

Abstract

dc:description.abstract

Aberrant expression of the B-cell lymphoma 6 (BCL6) oncoprotein has been associated with a large percentage of diffuse large B-cell lymphoma cases, the most common subset of Non-Hodgkin’s lymphoma. With cancers of this type highly dependent upon combination therapy, there is much desire to find more bioavailable and less cytotoxic treatment options than the current ‘gold’ standard. Here, homo- and heterodimeric protein-protein interaction inhibitors of the Nterminal Bric-a-brac tramtrack broad-complex (BTB) domain of BCL6 have been identified. This was achieved by combining a bacterial reverse two-hybrid system with a split intein based methodology to screen libraries of backbone cyclic peptides.<br/><br/>A bacterial reverse two-hybrid system for BTB homodimerisation was constructed, alongside two heterodimeric systems targeting the BCL6 and silencing mediator of retinoic acid and thyroid receptor corepressors. From these three systems a series of cyclic peptide sequences were identified that were found to exhibit inhibitory activity. These cyclic peptides were subsequently synthesised by solid phase peptide synthesis and their activity assessed using a range of in vitro based assays.<br/><br/>This research has resulted in the identification of one active cyclic peptide with mid micromolar affinity that has the propensity to disrupt BTB homodimerisation. In contrast, a number of active cyclic peptide inhibitors have been discovered against BTB heterodimerisation with the most potent inhibitors demonstrating corepressor specific activity despite a conserved binding site. These peptides provide a foundation for the future design of more potent inhibitors against BCL6.

Degree

thesis:*
Name dc:type.qualificationname
Ph.D.
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
University of Southampton
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Osher, Eliot
Advisor dc:contributor.advisor
  • Tavassoli, Ali
ORCID person:identifier.orcid

Rights

Language dc:language
English, eng

Chain of custody

source
Harvested from
University of Southampton
Base URL
eprints.soton.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Osher, Eliot. Inhibiting the protein-protein interaction of B-cell lymphoma 6 using genetically selected cyclic peptide inhibitors. doctoral thesis, University of Southampton, 2017.